These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
785 related articles for article (PubMed ID: 8891332)
1. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332 [TBL] [Abstract][Full Text] [Related]
2. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells. Carstens CP; Krämer A; Fahl WE Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G; Hunter T; Ruoslahti E Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134 [TBL] [Abstract][Full Text] [Related]
5. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells. Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451 [TBL] [Abstract][Full Text] [Related]
6. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197 [TBL] [Abstract][Full Text] [Related]
7. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells. Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783 [TBL] [Abstract][Full Text] [Related]
11. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267 [TBL] [Abstract][Full Text] [Related]
12. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells. Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340 [TBL] [Abstract][Full Text] [Related]
14. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
15. Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. Winston J; Dong F; Pledger WJ J Biol Chem; 1996 May; 271(19):11253-60. PubMed ID: 8626675 [TBL] [Abstract][Full Text] [Related]
16. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1). Wang G; Miskimins R; Miskimins WK Exp Cell Res; 2000 Jan; 254(1):64-71. PubMed ID: 10623466 [TBL] [Abstract][Full Text] [Related]
17. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
18. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes. McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885 [TBL] [Abstract][Full Text] [Related]
19. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745 [TBL] [Abstract][Full Text] [Related]
20. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]